Exploring the comparative cardiovascular death benefits of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoring

BACKGROUND AND AIMS: Cardiovascular death (CV death) is the most objective component of the primary or secondary endpoint in cardiovascular outcome trials (CVOTs) conducted with sodium–glucose cotransporter 2 inhibitors (SGLT-2is). CV death is often incorporated into primary composite outcomes. It i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosal, Samit, Sinha, Binayak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353048/
https://www.ncbi.nlm.nih.gov/pubmed/37469980
http://dx.doi.org/10.3389/fendo.2023.1168755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353048/
https://www.ncbi.nlm.nih.gov/pubmed/37469980
http://dx.doi.org/10.3389/fendo.2023.1168755

Ejemplares similares